Your browser doesn't support javascript.
loading
Induction intravenous cyclophosphamide followed by maintenance oral immunosuppression in refractory myasthenia gravis.
Buzzard, Katherine A; Meyer, Nicholas J; Hardy, Todd A; Riminton, D Sean; Reddel, Stephen W.
Affiliation
  • Buzzard KA; Department of Neurology, Concord Repatriation General Hospital, Concord West, New South Wales, 2139, Australia.
  • Meyer NJ; Department of Immunology, Concord Repatriation General Hospital, Concord West, New South Wales, Australia.
  • Hardy TA; Department of Neurology, Concord Repatriation General Hospital, Concord West, New South Wales, 2139, Australia.
  • Riminton DS; Department of Immunology, Concord Repatriation General Hospital, Concord West, New South Wales, Australia.
  • Reddel SW; Department of Neurology, Concord Repatriation General Hospital, Concord West, New South Wales, 2139, Australia.
Muscle Nerve ; 52(2): 204-10, 2015 Aug.
Article in En | MEDLINE | ID: mdl-25487528
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunosuppression Therapy / Cyclophosphamide / Immunosuppressive Agents / Myasthenia Gravis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Muscle Nerve Year: 2015 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunosuppression Therapy / Cyclophosphamide / Immunosuppressive Agents / Myasthenia Gravis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Muscle Nerve Year: 2015 Type: Article Affiliation country: Australia